artenimol has been researched along with Lupus Nephritis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Diao, L; He, W; Hu, Y; Tao, J; Wang, Y | 1 |
Dong, YJ; Li, WD; Tu, YY | 1 |
2 other study(ies) available for artenimol and Lupus Nephritis
Article | Year |
---|---|
Co-Delivery Of Dihydroartemisinin And HMGB1 siRNA By TAT-Modified Cationic Liposomes Through The TLR4 Signaling Pathway For Treatment Of Lupus Nephritis.
Topics: Anti-Inflammatory Agents; Artemisinins; Cytokines; Gene Expression Regulation; Gene Products, tat; HMGB1 Protein; Humans; Liposomes; Lupus Nephritis; NF-kappa B; RNA, Small Interfering; Signal Transduction; Toll-Like Receptor 4 | 2019 |
[Effect of dihydro-qinghaosu on auto-antibody production, TNF alpha secretion and pathologic change of lupus nephritis in BXSB mice].
Topics: Animals; Antibodies, Antinuclear; Artemisinins; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Mice; Mice, Inbred Strains; Random Allocation; Sesquiterpenes; Tumor Necrosis Factor-alpha | 2003 |